This is potentially huge — and good — news for those of us who don’t have IPF. This approval is for those who have Scleroderma, but according to my nurse practitioner other clinical trials are showing equally encouraging results for pulmonary fibrosis caused by other autoimmune disorders. She expects FDA approval will get pushed through quickly.
This is indeed wonderful news Cynthia, I completely agree! 🙂
Thanks for sharing, I look forward to reading the full article after clinics today. Hope you’re doing well, thanks for being such a wonderful addition to our forums.
Pulmonary Fibrosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.